Sagefield Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Sagefield Capital’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,900	Closed	–	–	158
2022 Q2	$0	Hold	5,900	–	–	﹤0.01%	152
2022 Q1	$1K	Hold	5,900	–	–	﹤0.01%	146
2021 Q4	$3K	Buy	+5,900	New	+$4.12K	﹤0.01%	155

Other funds holding FLACW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Ensign Peak Advisors

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Sagefield Capital's FLACW Position: Q3 2022 in Review

Sagefield Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 5,900 shares.

Sagefield Capital first reported a position in FLACW in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q4 2021. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

Sagefield Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
Sagefield Capital sold 5,900 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022.
Sagefield Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q4 2021 and held it in 3 quarters.
Sagefield Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $3K in Q4 2021.
21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Sagefield Capital's 13F filing for Q3 2022, filed 14 Nov 2022.